Dihydroisotanshinone I and BMAL-SIRT1 Pathway in an In Vitro 6-OHDA-Induced Model of Parkinson’s Disease
Hui‐Chen Su(National Tainan Institute of Nursing), Cheng‐Ming Hsu(Chang Gung University)
Cited by 9
Related Papers
NVP-BEZ235, a dual PI3K-mTOR inhibitor, suppresses the growth of FaDu hypopharyngeal squamous cell carcinoma and has a synergistic effect with Cisplatin
|Cell Death Discovery|2018|48
NVP-BEZ235 Attenuated Cell Proliferation and Migration in the Squamous Cell Carcinoma of Oral Cavities and p70S6K Inhibition Mimics its Effect
|International Journal of Molecular Sciences|2018|14
6-shogaol is a potential treatment for Head and Neck Squamous Cell Carcinoma
|International Journal of Medical Sciences|2023|12